3
Announcements
Trials
Browse
Landscape
Status
Completed
2
No longer available
1
Approved for marketing
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Conditions
Prostatic Neoplasms
5
Recurrence
2
Neoplasms
2
Liver Neoplasms
2
Lambert-Eaton Myasthenic Syndrome
2
Carcinoma, Hepatocellular
2
Wounds and Injuries
1
Renal Insufficiency
1
Prostatic Diseases
1
Pheochromocytoma
1
Paraganglioma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Myasthenic Syndromes, Congenital
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Congenital Abnormalities
1
Colonic Neoplasms
1
Interventions
Amifampridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Approved for marketing
×
OTHER
×
Myasthenic Syndromes, Congenital
×
Clear all
NCT00872950
2022-04-11
LEMS
Lahey Clinic
Approved for marketing